Abstract:Objective The aim of this study is to determine the correlation between serum oxidized low-density lipoprotein (oxLDL), complement C1q/tumor necrosis factor related protein 5 (CTRP5) and monocyte chemotactic protein-1 (MCP-1) and hypertensive carotid atherosclerosis (CAS). Methods Based on the carotid intima-media thickness (CIMT), 143 hypertensive patients were divided into two groups: a normal group (n=61) and a CAS group (n=82). Additionally, 87 healthy individuals who underwent physical examinations were included in the control group. ELISA method was applied to measure serum levels of oxLDL, CTRP5, and MCP-1. The relationship between serum oxLDL, CTRP5, MCP-1 levels and CIMT was analyzed using Pearson correlation method. Logistic regression method was applied to explore the influencing factors of CAS occurrence in hypertensive patients. The diagnostic value of serum oxLDL, CTRP5, and MCP-1 in hypertensive CAS was investigated using receiver operating characteristic (ROC) curves. Results The levels of serum oxLDL, CTRP5, and MCP-1 in the control group, normal group, and CAS group all increased sequentially (P< 0.05). Pearson analysis showed a significant positive correlation between serum oxLDL, CTRP5, MCP-1 and CIMT (r=0.526, 0.592, 0.646, P<0.05). Logistic regression analysis suggested that homocysteine (Hcy), high-density lipoprotein (HDL-C), oxLDL, CTRP5, and MCP-1 were all influencing factors for the occurrence of CAS in hypertensive patients (P<0.05).The AUC of oxLDL, CTRP5 and MCP1 combined diagnosis was significantly higher than that of each index alone diagnosis (P<0.05). Conclusion The levels of serum oxLDL, CTRP5, and MCP-1 are all elevated in hypertensive CAS patients, and their expression levels are positively correlated with CIMT. Moreover, these three factors demostrate high diagnostic efficacy in diagnosing hypertensive CAS.